Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $989.0K | $1.9M | $674.0K | $343.0K | $578.0K | $699.0K | $381.0K | $0 |
| Cost of revenue | $8.3M | $9.4M | $7.8M | $6.1M | $4.7M | $5.1M | $4.1M | $5.4M |
| Gross profit | −$7.3M | −$7.4M | −$7.2M | −$5.7M | −$4.1M | −$4.4M | −$3.7M | −$5.4M |
| Gross margin | -742.2% | -382.9% | -1063.6% | -1669.1% | -705.2% | -631.2% | -967.5% | — |
| R&D | $9.8M | $9.4M | $7.8M | $16.1M | $4.7M | $5.1M | $4.1M | $5.4M |
| Operating income | −$11.8M | −$11.8M | −$11.3M | −$10.7M | −$7.0M | −$8.9M | −$8.0M | −$9.2M |
| EBITDA | −$10.6M | −$10.7M | −$9.5M | −$22.2M | −$5.7M | −$7.4M | −$7.2M | −$9.1M |
| Net income | −$11.7M | −$10.4M | −$9.1M | −$22.2M | −$5.5M | −$7.7M | −$7.1M | −$5.7M |
| Net margin | -1183.5% | -535.0% | -1355.8% | -6469.1% | -944.6% | -1095.3% | -1858.0% | — |
| EPS (diluted) | -5186.96 | -4853.08 | -325.57 | -143.27 | -35.25 | -49.43 | -2.29 | -11.57 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds MTP.
No tracked institution reports a position in MTP as of their last filing.
No one on the platform has traded MTP yet.
| $2M |
| — |
| ONCSQOncoSec Medical Incorporated | $0.00 | +0.00% | $596 | — |
| ONCTOncternal Therapeutics, Inc. | $0.53 | -24.12% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 0.5× historical median P/S.
Fair value ≈ $3.73 · price $0.29 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.